Patents Assigned to Incyte Genomics, Inc.
-
Patent number: 6432687Abstract: The invention provides a human delayed rectifier potassium channel subunit (DRPCS) and polynucleotides which identify and encode DRPCS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of DRPCS.Type: GrantFiled: December 22, 1999Date of Patent: August 13, 2002Assignee: Incyte Genomics, Inc.Inventors: Jennifer L. Hillman, Chandra Patterson, Neil C. Corley
-
Patent number: 6428949Abstract: The present invention provides a novel human phosphatase inhibitor protein (HPIP) and polynucleotides which identify and encode HPIP. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding HPIP and a method for producing HPIP. The invention also provides for agonists, antibodies, or antagonists specifically binding HPIP, and their use, in the prevention and treatment of diseases associated with expression of HPIP. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding HPIP for the treatment of diseases associated with the expression of HPIP. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding HPIP.Type: GrantFiled: March 4, 1999Date of Patent: August 6, 2002Assignee: Incyte Genomics, Inc.Inventors: Olga Bandman, Surya K. Goli
-
Patent number: 6426186Abstract: The invention provides polynucleotides and polypeptides that are co-expressed with genes known to be involved in bone remodeling and osteoporosis. The invention also provides expression vectors, host cells, and methods for making a polypeptide, for screening or purifying ligands, and for diagnosing disorders associated with bone remodeling or osteoporosis.Type: GrantFiled: January 18, 2000Date of Patent: July 30, 2002Assignee: Incyte Genomics, IncInventors: Karen A. Jones, Wayne Volkmuth, Michael G. Walker
-
Patent number: 6423535Abstract: Methods are provide for quantitatively determining the amount of polynucleotides in a sample. In one method, the distinct polynucleotide targets and standard polynucleotide targets are contacted with detectable probes and independently detectable single or double stranded complements to the standard targets under hybridization conditions. The hybridization pattern from the probe is compared to the hybridization pattern from the standard sequences to obtain quantitative information about the genetic profile of the labeled nucleic acid sample. Also provided are kits for the use of the methods.Type: GrantFiled: November 24, 1999Date of Patent: July 23, 2002Assignee: Incyte Genomics, Inc.Inventors: Lyle Arnold, Tod Bedilion, Erik Bjeldanes, Thomas P. Theriault, Warren Lei
-
Patent number: 6424921Abstract: Composite hybridization arrays and averaged hybridization arrays are provided. Composite hybridization arrays are formed from a user selected set of hybridization arrays, and once instantiated in a hybridization array database, are available for searching, analysis, and other data processing as with other types of hybridization arrays. This allows otherwise experiments using multiple different nucleotide microarrays to be efficiently consolidated and analyzed. Averaged hybridization arrays provided correctly averaged values from multiple user selected dual channel hybridization arrays.Type: GrantFiled: July 10, 2000Date of Patent: July 23, 2002Assignee: Incyte Genomics, Inc.Inventors: Robert V. Gupta, Kirindi V. M. Choi, Robert A. Brahms, Doris Chang, Darryl V. K. Chong, John D. Burrill, Gregory Marcus, Gabor T. Bartha, Richard Head
-
Patent number: 6420114Abstract: A method and apparatus is provided for mixing a film of fluid, particularly a film of chemical, biochemical, or biological fluids, undergoing a reaction. The apparatus comprises a means for creating a bubble within the film of fluid, and moving the bubble in the fluid, thereby mixing the fluid.Type: GrantFiled: December 6, 1999Date of Patent: July 16, 2002Assignee: Incyte Genomics, Inc.Inventors: Tod Bedilion, Lozen Titsworth, Erik Bjeldanes, Douglas Gilliland, Lyle Arnold
-
Patent number: 6416755Abstract: The invention provides a human beta-alanine-pyruvate aminotransferase (HAPA) and polynucleotides which identify and encode HAPA. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HAPA.Type: GrantFiled: June 13, 2000Date of Patent: July 9, 2002Assignee: Incyte Genomics, Inc.Inventors: Olga Bandman, Preeti Lal, Neil C. Corley
-
Patent number: 6417329Abstract: The present invention provides a human growth factor receptor binding protein (GRBP) and polynucleotides which encode GRBP. The invention also provides expression vectors, host cells, agonists, antisense molecules, antibodies, or antagonists. The invention also provides methods for producing GRBP and for treating disorders associated with expression of GRBP.Type: GrantFiled: November 20, 1998Date of Patent: July 9, 2002Assignee: Incyte Genomics, Inc.Inventors: Olga Bandman, Anthony P. Diegidio
-
Patent number: 6416991Abstract: The invention provides human cyclic nucleotide phosphodiesterases (HSPDE10A) and polynucleotides which identify and encode HSPDE10A. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists and methods for diagnosing or treating disorders associated with expression of HSPDE10A.Type: GrantFiled: June 14, 2000Date of Patent: July 9, 2002Assignee: Incyte Genomics, Inc.Inventors: Stephen C. Phillips, Jerry Lanfear, Lindsay Fawcett, Olga Bandman, Ian Harrow
-
Patent number: 6413722Abstract: Methods are provide for modifying a solid support, such as a glass slide, by silylating with an agent having the formula H2N—(CH2)n—SiX3 where n is between 1 and 10, and X is independently chosen from OMe, OEt, Cl, Br, or I, then activating with a crosslinking reagent, followed by reacting with an amine-containing polymer. The support can optionally be reacted with a crosslinking reagent again. The support thus modified may be used to make arrays and microarrays where a plurality of targets are stably associated with the support and arranged in a defined manner.Type: GrantFiled: March 22, 2000Date of Patent: July 2, 2002Assignee: Incyte Genomics, Inc.Inventors: Lyle J. Arnold, Samuel P. Sawan, Paul H. Lee
-
Patent number: 6410231Abstract: The invention provides methods, compositions and systems for detecting multiple single nucleotide polymorphisms (SNPs) in a population of target polynucleotides in parallel in a sandwich assay employing SNP probes, capture polynucleotides and, optionally, auxiliary polynucleotides. The relative affinities of the SNP probes for the corresponding SNP regions can be increased with reagents which normalize the melting temperatures of the probes and/or by positionally facilitating interactions between the SNP probe, the SNP region, the capture polynucleotide and/or the auxiliary polynucleotides, such as through a minor groove binder. The probes may comprise a degenerate set of all possible same-sized polynucleotides and the capture polynucleotides are generally immobilized and arrayed at corresponding discrete elements in high density.Type: GrantFiled: February 26, 1999Date of Patent: June 25, 2002Assignee: Incyte Genomics, Inc.Inventors: Lyle Arnold, Thomas Theriault, Tod Bedilion
-
Patent number: 6410267Abstract: The invention provides human GTPase-associated proteins (GPAP) and polynucleotides which identify and encode GPAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of GPAP.Type: GrantFiled: June 8, 2000Date of Patent: June 25, 2002Assignee: Incyte Genomics, Inc.Inventors: Olga Bandman, Preeti Lal, Karl J. Guegler, Neil C. Corley, Chandra Patterson
-
Patent number: 6403778Abstract: The present invention relates to a composition comprising a plurality of polynucleotide targets. The composition can be used as hybridizable array elements in a microarray. The present invention also relates to methods for screening compounds and therapeutic treatments for toxicological responses.Type: GrantFiled: August 28, 1998Date of Patent: June 11, 2002Assignee: Incyte Genomics, Inc.Inventors: Mary Jane Cunningham, Gary B. Zweiger, Scott R. Panzer, Jeffrey J. Seilhamer
-
Patent number: 6399301Abstract: The invention provides a human phospholipase A2 protein PHPLA2 and polynucleotides which identify and encode PHPLA2. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of PHPLA2.Type: GrantFiled: January 21, 2000Date of Patent: June 4, 2002Assignee: Incyte Genomics, Inc.Inventors: Phillip R. Hawkins, Olga Bandman, Karl J. Guegler, Purvi Shah, Neil C. Gorley
-
Patent number: 6399024Abstract: The invention provides multichannel pipette heads and autopipettors for loading, measuring, transporting and dispensing, particularly from one micro-plate to another. An exemplary multichannel pipette head comprises a pump housing, pistons, a drive plate, an aspiration drive and bearing rails, wherein the pump housing comprises chambers adapted to receive the pistons, the pistons each comprise a shaft, the drive plate retains the pistons and translocates the piston shafts through chambers, the aspiration drive translocates the drive plate along the bearing rails which pass through the drive plate and attach to the pump housing.Type: GrantFiled: February 1, 2000Date of Patent: June 4, 2002Assignee: Incyte Genomics, Inc.Inventors: JoeBen Bevirt, Josh Guyot
-
Patent number: 6399345Abstract: The present invention provides four NADH dehydrogenase subunits (designated individually as NDS-1, NDS-2, NDS-3, and NDS-4 and collectively as NDS) and polynucleotides which identify and encode NDS. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding NDS and a method for producing NDS. The invention also provides for use of NDS and agonists, antibodies, or antagonists specifically binding NDS, in the prevention and treatment of diseases associated with expression of NDS. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding NDS for the treatment of diseases associated with the expression of NDS. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding NDS.Type: GrantFiled: September 10, 1998Date of Patent: June 4, 2002Assignee: Incyte Genomics, Inc.Inventors: Olga Bandman, Surya K. Goli, Jennifer L. Hillman
-
Patent number: 6391580Abstract: The invention provides seven human Ras proteins (RASP) and polynucleotides which identify and encode RASP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of RASP.Type: GrantFiled: May 8, 1998Date of Patent: May 21, 2002Assignee: Incyte Genomics, Inc.Inventors: Jennifer L. Hillman, Y. Tom Tang, Preeti Lal, Karl J. Guegler, Neil C. Corley, Chandra Patterson, Sajeev Batra, Mariah R. Baughn
-
Publication number: 20020058241Abstract: The present invention provides polynucleotides encoding stem cell antigens, the partial sequences for which were initially isolated from THP-1 and bladder tumor cDNA libraries and which identify and encode novel human stem cell antigens. The invention provides for genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding the stem cell antigens. The invention also provides for the use of purified stem cell antigens for the diagnosis and treatment of diseases associated with the expression of the stem cell antigens. Additionally, the invention provides for antibodies, antisense molecules and inhibitors of the stem cell antigens.Type: ApplicationFiled: August 23, 2001Publication date: May 16, 2002Applicant: Incyte Genomics, Inc.Inventor: Janice Au-Young
-
Patent number: 6387613Abstract: The invention provides a human short-chain dehydrogenase (HSCD) and polynucleotides which identify and encode HSCD. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HSCD.Type: GrantFiled: February 11, 1999Date of Patent: May 14, 2002Assignee: Incyte Genomics, Inc.Inventors: Preeti Lal, Neil C. Corley
-
Patent number: 6387631Abstract: Methods are provide for modifying a solid support, such as a glass slide, by silylating with an agent having the formula H2N—(CH2)n—SiX3 where n is between 1 and 10, and X is independently chosen from OMe, OEt, Cl, Br, or I, then activating with a crosslinking reagent, followed by reacting with an amine-containing polymer. The support can optionally be reacted with a crosslinking reagent again. The support thus modified may be used to make arrays and microarrays where a plurality of targets are stably associated with the support and arranged in a defined manner.Type: GrantFiled: February 1, 2001Date of Patent: May 14, 2002Assignee: Incyte Genomics, Inc.Inventors: Lyle J. Arnold, Samuel P. Sawan, Paul H. Lee